When: Daily close below $662 with volume

Then: Trim to Underweight immediately

HOLD with conditional triggers; do not add at $682; await confirmed breakout above $703 with volume and MACD turning positive before scaling in 1% of book; trim immediately on close below $662

• TTM EPS of $17.99 vs forward consensus of $22.71 suggests 23 percent earnings beat required to reach $28 target
• Q3 FY26 showed sequential revenue decline of 5.6 percent quarter over quarter with gross margins compressed to 35.7 percent from 38.6 percent in FY24
• Stock at $682 is 16 percent above 200-day SMA at $587, at 84th percentile of 52-week range—a classic expensive entry for a cyclical
• MACD collapsed 55 percent from 17.83 to 8.03 in nine trading days, histogram at -3.27 with bearish signal line crossover
• VWMA stalling at $685 vs price at $682 indicates bearish volume divergence with sellers absorbing upside pressure
• Macro headwinds include 10Y at 2002 highs, 96 percent probability of zero Fed cuts in 2026, mortgage rates at 7.58 percent
• Structural interest expense of $3.17 billion annually from FY23 buyback binge not temporary
• Coiled Bollinger Band setup historically resolves in both directions; current positioning at 84th percentile increases downside risk
• Probability-weighted fair value brackets current price: $700 bull and $640 bear, making current levels roughly fairly priced
• Aggressive case's 2-3 percent incremental position at $682 on $25 billion book equals $500-750 million deployed into unresolved coil

→ vs aggressive: Earnings forecast from $22.71 to $28 is hope, not analysis—23 percent beat required; Q3 FY26 margin compression contradicts inflection narrative

→ vs aggressive: 200 SMA rising from $531 to $587 is mathematically lagging a 53 percent price rip, not fundamental strengthening; being 16 percent above long-term trend is not where conservative capital enters

→ vs aggressive: MACD 55 percent momentum collapse in nine days with histogram at -3.27 is not consolidation; VWMA at $685 vs price at $682 is distribution, not rebalancing

→ vs aggressive: Bollinger squeeze resolves in BOTH directions; framing coiled spring as preordained upside is selection bias, not analysis

→ vs aggressive: Front-running confirmation signal with 2-3 percent at 84th percentile into restrictive macro is momentum chasing, not conviction investing

→ vs neutral: Fair value bracketing at $700 and $640 is accurate framing but may underweight tail risks from rate environment and margin trajectory

HOLD with refined triggers; scale in 1.5% of book on confirmed breakout above 703, target 740-780, stop at 580

• HOLD is correct as base case; do not add at current price of 682 (84th percentile of 52-week range)
• TTM EPS 17.99, forward consensus 22.71; Q3 FY26 showed sequential revenue declining 5.6% QoQ with gross margins compressing to 35.7% from 38.6% in FY24
• 200 SMA at 587 with price at 682 = 16% above long-term trend (mature but not exhausted); 50 SMA at 650 is 12% below price
• MACD rolling from 17.83 to 8.03 in nine trading days with negative histogram is a real momentum shift warning
• VWMA stalling at 685 while price coils at 682 is distribution
• Coiled spring/squeeze expected move is only 1-2 ATRs (17-34 dollars), not the 740-780 target over 12-24 months
• Bull trigger: two consecutive daily closes above 703 with volume 15%+ above 20-day average and MACD histogram turning positive
• First scale-in: 1.5% of book on confirmed breakout; add 0.5-1% more on retest of 703-705 bringing total to 2-2.5%
• Bear trigger: daily close below 662 with volume; trim to underweight immediately
• Hard stop at 580; if scaled in 1.5% at 710, stop loss equals 1.5% of book drawdown
• Structural interest expense of 3.17 billion argues for modest recovery multiple, not return to 30-plus times peak
• Fundamentals improving (FCF trajectory, 18% ROE at trough, maintained R&D, fortress balance sheet) while technicals weakening suggests consolidation within uptrend, not reversal
• "Turning isn't the same as turned" is the most important framing
• Conservative 1% sizing is too small given thesis conviction; represents worst of both worlds
• Aggressive risk-reward of 3.5-5:1 is based on mixing near-term squeeze resolution with 12-24 month strategic target
• Macro restrictive but priced: 10Y at multi-year highs, 96% probability no Fed cuts, 7.58% mortgage rate, yet S&P 500 and Nasdaq at record highs

→ vs aggressive: Conviction level on inflection thesis is too high given recent Q3 FY26 print showing sequential revenue decline and margin compression

→ vs aggressive: Treating 200 SMA as a leading signal rather than a lagging confirmation indicator

→ vs aggressive: MACD framing of 'still positive at 8' is misleading; momentum has clearly shifted

→ vs aggressive: Mixing near-term squeeze resolution timeframe (1-2 ATRs) with 12-24 month strategic target (740-780) overstates risk-reward

→ vs aggressive: Pre-committing at 84th percentile of 52-week range with momentum rolling over is not disciplined risk management

→ vs conservative: Saying 200 SMA is just a lagging indicator that catches up to vertical moves dismisses its value in confirming uptrends with higher highs and higher lows

→ vs conservative: Single daily close above 703 with all three criteria is too tight; will get 1-2 setups per year at suboptimal entry points

→ vs conservative: 1% sizing is too small for a 12-24 month cycle inflection thesis; represents worst of both worlds

→ vs conservative: Asymmetric risk framing ignores opportunity cost: if squeeze breaks up to 740 and you scale in 1% at 710, you capture only 0.03% of portfolio on the move

→ vs conservative: Rate story is not the dominant driver when DE rallied 53% while yields rose; replacement cycle is

→ vs conservative: Being 'too patient' has real opportunity cost if breakdown reverses and rallies to 800